Urine-Based Stem Cell Isolation for Kidney Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for kidney diseases, particularly end-stage renal disease, are invasive and costly, with stem cell collection methods posing significant risks, and there is a need for a less invasive and effective method to collect and utilize podocyte progenitor cells for kidney regeneration.
Innovation Solution
A method involving the collection, isolation, and culturing of podocyte progenitor cells and neural stem/progenitor cells from urine specimens, which includes centrifugation, cell marker expression analysis, and in vitro growth, followed by implantation into the kidney or central nervous system for treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bone marrow cells are used as a source of stem cells, then stem cell therapy can be provided, but the procedure becomes invasive with significant risks
Solution Approach 1:
The patent extracts the useful stem cell function from the harmful bone marrow collection procedure by identifying and isolating podocyte progenitor cells that naturally circulate in urine. This allows obtaining stem cells without the invasive bone marrow puncture procedure, thereby maintaining therapeutic effectiveness while eliminating the harmful invasive aspect.
Solution Approach 2:
The patent uses urine as an intermediary medium to access stem cells. Instead of directly accessing bone marrow, the method collects stem cells that are naturally excreted in urine, using the urinary system as an intermediary pathway to obtain therapeutic cells without invasive procedures.
2Quantity of substance
If traditional stem cell collection methods are used, then stem cells can be obtained, but the procedure is invasive and carries significant risks
Solution Approach 1:
The patent employs a self-service approach where the patient's own body naturally excretes stem cells in urine, which can be collected without medical intervention. This eliminates the need for invasive collection procedures while maintaining adequate stem cell availability for therapy.
Solution Approach 2:
The method extracts stem cells from urine, a readily accessible bodily fluid, rather than requiring invasive procedures. This provides sufficient stem cell quantity through a simple urine collection process that any patient can perform.
3Reliability
If invasive procedures are used to collect stem cells, then stem cell therapy can proceed, but patient burden and healthcare costs increase
Solution Approach 1:
The patent extracts the essential therapeutic element (stem cells) from a complex invasive procedure by obtaining them directly from urine. This simplifies the entire treatment pathway from collection to therapy while maintaining effectiveness, reducing both procedural complexity and associated costs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a non-invasive and patient-friendly method for regenerating kidney cells, potentially treating kidney diseases and central nervous system conditions by utilizing cells that can differentiate into mature podocytes and neural cells, offering a promising alternative to traditional stem cell therapies.
Implementation Method 1
centrifuging the urine specimen, and removing the one of podocyte progenitor cells and neural stem/progenitor cells
Data Source
AI summary
A method of generating one of podocyte progenitor cells and neural stem/progenitor cells comprising the steps of collecting a urine specimen from a patient; centrifuging the urine specimen; and removing the one of podocyte progenitor cells and neural stem/progenitor cells.